CR

CorVel Corporation

CRVLFinancial ServicesNASDAQ

Insurance Brokers · Last scanned Sep 8, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$958.5M
+7.0% YoY
Net Income
$110.3M
+16.0% YoY
EBITDA
$174.9M
+16.3% YoY
Free Cash Flow
$91.7M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 RSI OverboughtRSI 74.1, above 70, stock may be overbought
Sep 2 RSI OverboughtRSI 76.1, above 70, stock may be overbought
About CorVel Corporation

CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. The company carries a $3.45B market cap, placing it firmly in the mid-cap category. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.

Where CRVL stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, CRVL finished 20.45% above its 150-day moving average ($58.44) and 14.68% above its 200-day moving average ($61.38). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CRVL overbought or oversold?

At the September 3, 2026 close, CRVL's RSI(14) was 74.1, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$3.45B
P/E (TTM)30.32
EPS$2.25
Beta0.97
52W Change-22.1%
ROE30.7%
Analysis

With $255.9M in cash and $28.4M in debt, CRVL maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $91.7M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 30.7% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 14.7% further supports the picture of efficient asset utilization. Revenue has grown from $718.6M (2023) to $958.5M (2026), reflecting a 33% increase over the period.

With cash comfortably exceeding debt, CRVL has financial flexibility that may help navigate uncertain periods. No single metric tells the full story. Reviewing CRVL's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Financial Services stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms